medcareworld

medcareworld

Hospitals and Health Care

A leading bespoke elective care solutions provider to the NHS delivering clinical excellence for nearly 10 years.

About us

Who Are Are & Our Core Work Founded in 2015, medcareworld (Gutcare) is a leading healthcare provider of outstanding end-to-end clinical insourcing solutions to the NHS across all elective care specialties across the whole of the UK and Ireland. We are extremely proud that our work over the last near decade, delivering expert care to over 100,000 patients, has produced outstanding results for our NHS partners. What We Do We work with NHS Trusts as a dedicated and committed partner, delivering safe, high quality, cost-effective solutions to reduce elective patient care backlogs with the help of our highly experienced clinical teams. How We Do It? When you collaborate with us our bespoke service aims to design personalised healthcare pathways which seamlessly blend in and complement your individual specialist area needs. We believe bespoke solutions enhance overall patient care that in turn improve health outcomes "because patients are at the heart of everything we do." Why Work With Us? We are chosen as health solutions partners because of our: •Adherence to strong clinical governance led by expert clinical leads •Integrated service that supports the patient throughout their journey •Rapid mobilisation programs, bespoke to our partners’ needs •Collaborative approach to deliver a full range of primary and secondary patient services on estate or in the community Clinical Areas Covered By Us: •Endoscopy •Gastroenterology •General Surgery •Vascular Surgery •Urology and Renal Medicine •Cardiology including Echocardiogram •Ophthalmology •Gynaecology •ENT •Mental Health •Orthopaedics •Paediatrics •Rheumatology •Imaging •Theatre Services

Industry
Hospitals and Health Care
Company size
11-50 employees
Headquarters
Hornchurch
Type
Privately Held
Founded
2015
Specialties
Endoscopy, ODP/Aanaesthetics, Urology, Gynaecology, Ophthalmology, Dermatology, Orthopaedics, Paediatrics, Rheumatology, Radiology, ENT, Neurology, Mental Health, Oncology, General Surgery, Renal Medicine, Gastroenterology, Vascular Surgery , Theatre Services, and Cardiology

Locations

Employees at medcareworld

Updates

  • 🎄 Wishing You a Very Merry Christmas and a Bright New Year from All of Us at medcareworld! 🎄 As we wrap up 2024, we want to take a moment to express our heartfelt gratitude to our amazing team, wonderful clients, and valued partners. This year has been extraordinary, and it is all because of your trust, collaboration, and unwavering support. Looking ahead to 2025, we’re filled with excitement to continue creating innovative health solutions that truly make a difference. Whether tackling complex challenges or opening new opportunities, we’re dedicated to empowering better health outcomes for everyone we serve. At medcareworld, our mission remains steadfast: prioritising safety, trust, and meaningful results in everything we do. This Christmas, we hope you find time to relax, celebrate, and enjoy the company of loved ones. Here’s to a season filled with peace and happiness and a New Year brimming with opportunity, success, and health. Thank you for being part of our journey—2025 is just the beginning! #MerryChristmas #Healthcare #HealthcareInnovation #Gratitude #NewYearNewPossibilities #NewYear #NHS #HealthSolutions #Patients #Carers #Families #HolidaySeason

  • Addressing NHS Challenges in 2024: Our Year So Far  As we approach the end of 2024, it’s clear this has been another year of significant challenges and progress for the NHS. Backlogs and waiting lists remain pressing issues, but we’re proud of the role we’ve played in tackling these head-on through clinical insourcing.  At medcareworld, we’ve seen a year of growth, collaboration, and measurable impact. By working closely with NHS trusts, we’ve been able to deliver vital services that have reduced patient waiting times, improved access to care, and alleviated pressure on overstretched resources.  Milestones from 2024  Patients Served: This year, our teams have supported thousands of patients by directly addressing their needs, helping them avoid potentially lengthy delays.  Expanding Partnerships: We’ve collaborated with more NHS trusts, bringing our expertise to even more regions and ensuring our work has a broader national impact.  Speciality Growth: From diagnostic imaging to elective surgeries, and dermatological to cancer screening, we’ve expanded our offerings to cover more specialities, filling critical gaps in service provision.  Efficiency Gains: Through innovative scheduling and deployment models, such as evening and weekend clinics, we’ve helped NHS trusts maximise their resources while maintaining high-quality care.      Building Momentum into 2025  While the year isn’t over yet, we’re already building on the momentum of 2024 and preparing for an even bigger impact in 2025. Some of the initiatives we’re excited about include:  Scaling Services Further: We’re preparing to launch new services allowing us to address bottlenecks in even more areas.  Leveraging Technology: Our investment in new technology and AI-assisted diagnostics will help improve patient outcomes and make care delivery more efficient.  Patient-Centred Innovations: We’re rolling out more service innovations to ensure every individual receives the care and attention they deserve.  Thank You for Your Support  Our journey this year wouldn’t have been possible without the incredible dedication of our teams, the collaboration of NHS trusts, and the trust of patients. Together, we’ve made a tangible difference and set the stage for even greater achievements.  As we enter the final stretch of the year, we remain focused on delivering results and making an impact where it matters most. Here’s to ending 2024 on a strong note and continuing this vital work into the new year.  Stay tuned for updates on our latest projects and milestones as we move forward!  #NHS2024 #HealthcareInnovation #PatientCare #ClinicalInsourcing #HealthcareImpact #ReducingWaitingTimes#NHS #MedicalPartnerships #FutureOfHealthcare #HealthcareLeadership #PatientFirst #BetterHealthcareForAll   

  • A New Era for Men’s Health: Why It Matters and How We Support It The UK government’s announcement yesterday of the first-ever Men’s Health Strategy is a landmark step in tackling the unique challenges men face in accessing and benefiting from #healthcare. As a company working closely with the NHS, we welcome this focus on improving men’s health and addressing long-standing inequalities. The Case for Action Men face disproportionately poor health outcomes, often with tragic consequences: Life expectancy: Men live, on average, four years less than women (Office for National Statistics). Suicide rates: Men account for 75% of UK suicides, the leading cause of death for men under 50 (Samaritans). Chronic disease: Men are 14% more likely to develop heart disease and 22% more likely to have diabetes than women (British Heart Foundation). Prostate cancer: Over 47,000 men are diagnosed annually, often too late due to limited routine screening (Prostate Cancer UK). These disparities represent a pressing challenge for both #publichealth and the #NHS. Our Role in Driving Change Our company supports men’s health by working with NHS trusts to deliver targeted, effective solutions: 1. Reducing Waiting Lists: We provide diagnostic and surgical capacity to ensure timely treatment for conditions like prostate cancer and other urological diseases, improving outcomes and reducing delays. 2. Promoting Early Action: We support NHS efforts to deliver screening and outreach clinics, encouraging men to engage with their health before problems escalate. 3. Supporting Mental Health: Mental health remains an often-overlooked aspect of men’s care. We integrate mental health support into treatment pathways, particularly for patients with life-changing diagnoses. 4. Addressing Inequalities: Men in deprived areas face worse outcomes. Our data-driven approach helps the NHS focus resources where they’re needed most. Prevention and Health Equity The Men’s Health Strategy aligns with the NHS’s push for #preventativecare. Educating men about common conditions, removing barriers to access, and engaging underserved communities are key to reducing avoidable illnesses and easing pressure on NHS services. While this strategy focuses on men, it complements the Women’s Health Strategy, ensuring gender-specific needs are met without compromising health equity. As an NHS partner, we’re committed to: Expanding diagnostic and surgical access for men’s health issues. Supporting preventative health initiatives to tackle chronic diseases early. Collaborating on innovative approaches to reduce health inequalities. The Road Ahead The Men’s Health Strategy is a vital step forward, but its success depends on #collaboration across the healthcare sector. By addressing men’s health proactively, we can save lives, reduce NHS burdens, and create a more equitable future for all. Learn more: https://lnkd.in/eCkv7miF 

    Secretary of State commits to first ever men’s health strategy

    Secretary of State commits to first ever men’s health strategy

    gov.uk

  • Pancreatic Cancer Awareness Month – We’re halfway through pancreatic cancer awareness month, one of the most challenging cancers to detect and treat. As a company committed to supporting early diagnosis to help patients manage, treat, and, ultimately, survive serious health conditions, this month, we stand in solidarity with patients, families, healthcare providers, and advocates who work tirelessly to fight pancreatic cancer.  Why Pancreatic Cancer Awareness Matters  #PancreaticCancer is notoriously difficult to diagnose early as its symptoms often appear only in the advanced stages, when treatment options are limited. In the UK, pancreatic cancer has one of the lowest survival rates of any cancer, with only around 7% of patients surviving five years after diagnosis. This low survival rate can be attributed, in part, to delays in diagnosis and the aggressive nature of the disease.  Key Facts About Pancreatic Cancer  High Mortality Rate: Pancreatic cancer is the fifth most common cause of cancer death in the UK, but research indicates it could become the fourth leading cause by 2030.  Late Diagnosis: Over 80% of pancreatic cancer cases are diagnosed at a late stage. This is due to the subtle and non-specific symptoms, such as back pain, jaundice, and unexplained weight loss.  Research Funding: Despite its severity, pancreatic cancer receives significantly less funding compared to other types of cancer, with only around 3% of UK cancer research funding directed towards it.  The Importance of Early Diagnosis  Early diagnosis is essential in improving survival rates. Studies have shown that if pancreatic cancer is detected at an early stage, surgery may offer a chance for long-term survival. However, since early symptoms are minimal or mistaken for other common conditions, there’s a critical need for increased awareness, more funding for research, and improved diagnostic technologies.  How You Can Help This November  There are many ways to contribute to the fight against pancreatic cancer. Awareness is the first step. Throughout November, charities such as Pancreatic Cancer UK and Pancreatic Cancer Action are hosting events, sharing stories, and raising funds to drive research and support. By donating or participating in awareness activities, we can help fund essential research and provide better support for those affected.  Together for a Healthier Future  #PancreaticCancerAwarenessMonth reminds us of the urgency of early detection and the power of community and innovation. With continued advancements in diagnostics and a commitment to early intervention, we can work toward improving the lives of those impacted by pancreatic cancer.   This November, let’s make a difference by raising awareness, supporting research, and fostering a healthcare landscape where early diagnosis is the norm.  #EarlyDiagnosis #PatientCare #CancerOutcomes  #HealthcareInnovation #EarlyDetection #CancerResearch #HealthSolutions #BetterOutcomes #NHS

  • View organization page for medcareworld, graphic

    1,561 followers

    World Diabetes Day 2024: Confronting the Diabetes Epidemic with Innovation and Personalised Care World Diabetes Day draws attention to one of the most urgent public health challenges worldwide. In the UK, diabetes affects more than 5.6 million people and puts 13.6 million more at risk of developing type 2 diabetes. The #NHS spends around £10 billion annually—about 9% of its entire budget—managing diabetes and its complications. The #diabetes burden emphasises the importance of efficient, timely care to prevent complications and support healthier lifestyles. As diabetes rates continue to rise, personalised medicine and lifestyle-focused care are emerging as vital tools in diabetes prevention, treatment, and management. These approaches not only offer the potential for better health outcomes but also alleviate some of the demand on the NHS. While genes play a role in diabetes risk, lifestyle factors—such as diet, physical activity, and weight management—are key in preventing and managing type 2 diabetes. The NHS’s Diabetes Prevention Programme underscores this connection, helping at-risk individuals make sustainable lifestyle changes that can delay or prevent the onset of type 2 diabetes. The Broader Health Impact of Diabetes  Diabetes affects far more than blood sugar levels. Without proper management, it can lead to severe health complications, including: Cardiovascular Disease: People with diabetes are twice as likely to develop heart disease and stroke, making cardiovascular care essential in diabetes management. Kidney Disease: Diabetes is a leading cause of chronic kidney disease and kidney failure in the UK, underscoring the importance of regular screening and blood sugar control. Vision Loss: Diabetic retinopathy, caused by damage to the retina, remains a leading cause of blindness among working-age adults. Neuropathy and Amputation: High blood sugar can damage nerves, particularly in the feet, increasing the risk of serious infections and amputations. For healthcare providers, supporting the NHS to manage diabetes means providing not only medical care but also multidisciplinary support that addresses the wider health impacts of diabetes. Support from Charities and Organisations  Several UK and global organisations support diabetes awareness, care, and research: Diabetes UK: https://lnkd.in/dFka_8J  JDRF UK: https://lnkd.in/eTcWg_2j  International Diabetes Federation (IDF): https://idf.org/  The Global Diabetes Community: https://lnkd.in/dshdAgYD World Diabetes Day reminds us that diabetes is not only a medical issue but a public health crisis affecting millions in the UK. By leveraging #personalisedmedicine, promoting healthy lifestyle changes, and supporting #publichealth initiatives, we can improve outcomes for people with diabetes and reduce the burden on our healthcare system. #WorldDiabetesDay #DiabetesAwareness #HealthyLifestyle #medcareworld #HealthcareInnovation #DiabetesUK #JDRF #IDF #DiabetesPrevention

    • No alternative text description for this image
  • Our Future Health: Bringing Preventative Health Research to Communities via Tesco Our Future Health UK, now the UK’s largest health research programme, is expanding its reach through a new partnership with Tesco. This initiative will allow millions of UK adults to participate in health research through accessible in-store appointments. Funded by UK Research and Innovation (UKRI), Our Future Health is a collaboration between the public sector, life sciences companies, and leading health charities, and aims to enrol 5 million adults, gathering a vast dataset on health, genetics, and lifestyle to drive preventative healthcare. The programme’s goal is to proactively address major health issues like #cancer, #Alzheimer’s, #heartdisease, #arthritis, #diabetes and #stroke by gathering data on both genetic and environmental factors, including epigenetic markers. This focus on genetics and epigenetics offers insights into how lifestyle and environment may influence gene expression and disease risk, advancing the development of targeted, early-intervention strategies in public health. By making participation convenient and inclusive, Our Future Health hopes to capture diverse health insights that will pave the way for more personalised, preventative healthcare solutions across the UK, ultimately fostering healthier, happier lives. As a health solutions company, we at medcareworld are excited to see the impact of these efforts. We strongly believe that early detection and diagnosis can significantly benefit individuals by enabling timely interventions that slow or even halt disease progression. This aligns closely with our commitment to improving health outcomes and enhancing quality of life. To read more about this initiative, see the announcement from Our Future Health by visiting: https://lnkd.in/e2xkq-HN. #genetics #epigenetics #preventativehealth #healthcaresolutions #earlydiagnosis #publichealth #uk #healthresearch #healthinsights #personalisedhealthcare #futureofhealth

    UK’s largest health research programme will be delivering appointments in Tesco stores

    UK’s largest health research programme will be delivering appointments in Tesco stores

    ourfuturehealth.org.uk

  • View organization page for medcareworld, graphic

    1,561 followers

    Lung Cancer Awareness Month: We advocate Early Detection for Better Outcomes Lung cancer remains the most commonly diagnosed cancer and is the leading cause of cancer death worldwide with around estimated 1.8 million deaths in 2022 (World Cancer Research Fund International) accounting for the highest mortality rates among both men and women (World Health Organization). It is a significant contributor to cancer deaths here in the UK, with around 49,200 people diagnosed annually (Cancer Research UK (CRUK). However, early detection can make a critical difference—improving survival rates and offering patients a much better chance for recovery. Early-stage lung cancer detection can raise five-year survival rates to 56%, compared to just 5% in late-stage cases. As part of the NHS commitment to early diagnosis, free lung health checks are available to higher-risk individuals through the Targeted Lung Health Check (TLHC) program, aiming to catch potential cases sooner. To see if you or a loved one qualifies, learn about these screenings via the NHS website. We are proud to stand alongside our NHS partners and dedicated charities like Macmillan Cancer Support in the mission to reduce lung cancer’s toll on individuals and families across the UK. These organisations offer critical resources and mental health support to patients and their families, building a network of care that goes far beyond treatment. At medcareworld, we believe preventive health is key to reducing lung cancer’s impact on public health. Through our partnerships, we’re working to make diagnostics more accessible and timelier, helping to ensure that every patient has a chance at the best possible outcome.    This Lung Cancer Awareness Month, let’s encourage everyone to prioritise their lung health—whether by understanding risk factors, scheduling a screening, or sharing information with those who may need it. Together, we can change the story on lung cancer. Early detection saves lives, and we’re committed to making that a reality. Here are essential UK resources for information, support, and guidance: NHS Lung Health Check: Free screenings for higher-risk individuals to support early detection. More info: https://lnkd.in/eZcKScaR. Cancer Research UK: Info on lung cancer symptoms, treatments, and research. More info: https://lnkd.in/gbr3uPDv. Macmillan Cancer Support: Helpline, online communities, and local support. Call 0808 808 0000 or visit https://lnkd.in/gmfbxP7. Roy Castle Lung Cancer Foundation: UK’s only lung cancer charity offering support groups and grants. More info can be found at https://www.roycastle.org/. Asthma + Lung UK: Resources and patient support for lung health are available at https://lnkd.in/g5suPemd. #LungCancerAwareness #EarlyDetection #PreventiveHealth #NHS #Screening #LungHealth #PublicHealth #medcareworld #HealthcareSolutions #PatientCare #ClinicalExcellence

    • No alternative text description for this image

Similar pages